Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
- Conditions
- LymphomaDiffuse Large B-Cell Lymphoma and Follicular LymphomaRelapsed and Refractory
- Interventions
- First Posted Date
- 2014-11-04
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT02282358
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors
- Conditions
- Advanced Solid TumorsMetastatic Solid Tumors
- Interventions
- Biological: Mogamulizumab (KW-0761)
- First Posted Date
- 2014-11-02
- Last Posted Date
- 2021-04-23
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT02281409
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer
- Conditions
- Bladder CancerHigh Risk Superficial
- Interventions
- Biological: Bacillus Calmette-Guérin (BCG)
- First Posted Date
- 2014-11-02
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 80
- Registration Number
- NCT02281383
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Radiation: external beam radiation therapyRadiation: brachytherapyBehavioral: questionnaires
- First Posted Date
- 2014-10-31
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 45
- Registration Number
- NCT02280356
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery
- Conditions
- Metastatic Spine Lesions
- Interventions
- Radiation: single-fraction radiationDevice: MRI and/or CT
- First Posted Date
- 2014-10-30
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT02278744
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer
- First Posted Date
- 2014-10-29
- Last Posted Date
- 2023-04-07
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 29
- Registration Number
- NCT02278055
- Locations
- 🇺🇸
New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸University of North Carolina, Chapel Hill, North Carolina, United States
A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients
- Conditions
- Pediatric PateintsAmnesic Properties of Propofol
- Interventions
- Other: memory test
- First Posted Date
- 2014-10-29
- Last Posted Date
- 2018-01-10
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 69
- Registration Number
- NCT02278003
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity
- Conditions
- Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients
- Interventions
- Device: cardiac MRI with DWI
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2020-09-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 28
- Registration Number
- NCT02274480
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
- Conditions
- Ovarian CancerEndometrial Cancer
- Interventions
- First Posted Date
- 2014-10-21
- Last Posted Date
- 2021-04-23
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 23
- Registration Number
- NCT02269293
- Locations
- 🇺🇸
Memoral Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
- Conditions
- Allogeneic Hematopoietic Stem Cell
- Interventions
- Other: No fecal microbiota transplantation (FMT), routine managementBiological: fecal microbiota transplantation (FMT)
- First Posted Date
- 2014-10-20
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 59
- Registration Number
- NCT02269150
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States